At a glance
- Originator National Institutes of Health (USA)
- Developer Chiron Corporation; National Institutes of Health (USA)
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 26 Jul 2001 No-Development-Reported for Autoimmune disorders in USA (Unknown route)
- 26 Jul 2001 No-Development-Reported for Graft-versus-host disease in USA (Unknown route)
- 19 Apr 1996 Preclinical development for Autoimmune disorders in USA (Unknown route)